• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 25, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Living with and beyond advanced cancer: understanding patient needs and experiences

by
October 25, 2026
in Cancer
Reading Time: 2 mins read
0
Living with and beyond advanced cancer: understanding patient needs and experiences

Living with and beyond advanced cancer: understanding patient needs and experiences

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

People receiving ongoing treatment for advanced cancer in Canada report persistent symptoms, uncertainty about the future, disruptions to daily life and difficulty finding support that addresses their needs, according to a qualitative study of 22 participants. The research identified two overarching themes: challenges associated with living long-term with advanced cancer, and barriers and facilitators affecting participants’ ability to live well while continuing treatment.

The study examined the lived experiences of Canadians receiving ongoing treatment for advanced cancer through semi-structured virtual interviews. Interviews were audio-recorded, transcribed verbatim and analysed thematically using descriptive techniques. This exploratory design was intended to explore experiences and challenges rather than measure how common particular needs are across the Canadian population. The findings therefore reflect the accounts of the 22 people interviewed and do not establish national prevalence.

Participants described difficulties that appeared distinct from those associated with earlier-stage cancers and treatment delivered with curative intent. Persistent treatment-related symptoms created continuing physical challenges, while uncertainty about the future affected how participants approached their lives. Ongoing treatment also disrupted everyday routines, responsibilities and personal identity. In this way, the burden described by participants extended beyond the direct management of cancer to encompass practical, emotional and adjustment-related demands.

The second overarching theme concerned the factors that helped or hindered participants’ ability to live well. Their capacity for self-management and self-advocacy, support from family and friends, financial considerations and support from healthcare providers all influenced their experiences. Participants nevertheless reported difficulty navigating available resources and described limited guidance from providers. They felt that existing supports and resources were insufficient to respond to the combined challenges they encountered, leaving participants to address unmet needs themselves.

The authors note that advances in precision oncology and cancer therapies have improved survival for Canadians with advanced cancer, creating a growing population living long-term while receiving ongoing treatment. Yet little is known about the supportive-care needs of this group or how those needs differ from those of people treated with curative intent. The study suggests that existing supports are rarely effective at addressing the physical, emotional, practical and adjustment-related challenges reported by participants. Future research should therefore develop and adapt accessible, tailored supports for people living with advanced cancer. Because the study included only 22 remotely interviewed participants, it cannot determine whether particular needs are more common among specific demographic groups, cancer types or regions, nor can it establish whether new support services would improve clinical outcomes.

Subject of Research: Lived experiences and supportive-care needs of Canadians receiving ongoing treatment for advanced cancer

Article Title: Living with and beyond advanced cancer: understanding patient needs and experiences

Article References: Scruton, S., Kendell, C., Pauling, J., Aizenberg, Y., Wallace, A., Trottier, A., Reiman, T., Thoms, J., & Urquhart, R. (2026). Living with and beyond advanced cancer: understanding patient needs and experiences. BMC Cancer. https://doi.org/10.1186/s12885-026-16808-3

Image Credits: AI Generated

DOI: 10.1186/s12885-026-16808-3

Keywords: advanced cancer, ongoing cancer treatment, supportive care, patient experiences, qualitative interviews, Canada, self-management, healthcare navigation, treatment uncertainty, Living, beyond, advanced

News Source: Nathaniel Bowman. (October 25, 2026). Living with and beyond advanced cancer: understanding patient needs and experiences. Scienmag.

Tags: Advancedadvanced cancerBeyondCanadahealthcare navigationlivingongoing cancer treatmentPatient experiencesqualitative interviewsself-managementsupportive caretreatment uncertainty
Share12Tweet7Share2ShareShareShare1

Related Posts

Surgery and radiotherapy linked to longer survival in grade 4 brain tumors

Surgery and radiotherapy linked to longer survival in grade 4 brain tumors

October 25, 2026
Antibody-Drug Conjugate Cuts Death Risk by 54% in Relapsed Small-Cell Lung Cancer

Antibody-Drug Conjugate Cuts Death Risk by 54% in Relapsed Small-Cell Lung Cancer

October 25, 2026

Meta-analysis links serum TK1 to prostate cancer and tumor grade

October 25, 2026

B7-H3 antibody-drug conjugate cuts death risk 54% in relapsed small-cell lung cancer

October 25, 2026

POPULAR NEWS

  • Flavonoids, not just diterpenoids, give South African medicinal spurflowers their chemical identities

    Flavonoids, not just diterpenoids, give South African medicinal spurflowers their chemical identities

    29 shares
    Share 12 Tweet 7
  • Body tissue links miniature implants to wearable health devices

    29 shares
    Share 12 Tweet 7
  • Photodynamic therapy shows promising HPV results in real-world CIN1 cohort

    29 shares
    Share 12 Tweet 7
  • Competing-risk analysis of tuberculosis outcomes in Liangshan

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Flavonoids, not just diterpenoids, give South African medicinal spurflowers their chemical identities

Body tissue links miniature implants to wearable health devices

Photodynamic therapy shows promising HPV results in real-world CIN1 cohort

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.